PPARG and lung carcinoma: Interestingly, both in vitro8–10 and in vivo11 studies have shown that activating peroxisome proliferator-activated receptor gamma (PPARG) slows down the growth of NSCLC lung cancer cells and/or might help stop the spread of developed NSCLC12.